Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Safe Supply Announces Strategic Expansion into AI-Powered Healthcare Solutions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Iovance Biotherapeutics Inc IOVA

Healthcare Biotechnology
Iovance Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company develops and delivers tumor infiltrating lymphocyte (TIL), therapies for patients with solid tumor cancers. Its lead product candidate, Amtagvi (lifileucel), is a tumor-derived autologous T cell immunotherapy indicated for the treatment of adult patients with unresectable or metastatic melanoma previously... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:IOVA)

Iovance Biotherapeutics to Present at Upcoming Conferences and Events

GlobeNewswire 7 days ago

Iovance Biotherapeutics Announces Clinical Data in Frontline Advanced Melanoma at ASCO 2024 Annual Meeting

GlobeNewswire 8 days ago

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire May 17, 2024

Iovance Biotherapeutics Reports First Quarter 2024 Financial Results and Corporate Updates

GlobeNewswire May 9, 2024

Iovance Biotherapeutics to Host First Quarter 2024 Financial Results Conference Call and Webcast on Thursday, May 9, 2024

GlobeNewswire May 1, 2024

Iovance Biotherapeutics to Present at Upcoming Conferences

GlobeNewswire April 30, 2024

Iovance Biotherapeutics to Present Clinical and Translational Data at 2024 ASCO Annual Meeting

GlobeNewswire April 24, 2024

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire April 19, 2024

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire March 22, 2024
View More News ››

Opinion & Analysis (NDAQ:IOVA)

Iovance Biotherapeutics Shares Rise 12% on Updated Phase 2 Melanoma Study Results

Streetwise Reports November 12, 2019

Preliminary Phase 2 clinical data provides 'first spark to game-changing thesis'

Streetwise Reports January 31, 2018

Cell therapy for melanoma impresses in Phase 2

The Life Sciences Report August 10, 2017
View More Opinion ››

Bullboard Posts (NDAQ:IOVA)

Today's Big Lunch Trades 21 Feb 2024

NEWS: $IOVA Today's Big Lunch Trades 21 Feb 20242024-02-21 13:09:13 ET DENVER, Colo., Feb 21, 2024 (www.247marketnews.com)- Midday...
whytestocks - February 21, 2024

Iovance Biotherapeutics Hits New 52-Week High

JUST IN: $IOVA Iovance Biotherapeutics Hits New 52-Week High2024-02-21 11:42:05 ET DENVER, Colo., Feb 21, 2024 (www.247marketnews.com...
whytestocks - February 21, 2024

Iovance Biotherapeutics Inc. (NASDAQ: IOVA) Near Top of Volu

NEWS: $IOVA Iovance Biotherapeutics Inc. (NASDAQ: IOVA) Near Top of Volume Charts in Tuesday TradingIovance Biotherapeutics, Inc...
whytestocks - February 20, 2024
View more Bullboard ››

Multi-Metal Development Ltd

Multi-Metal Development Ltd

Multi-Metal Development Ltd is a Canada-based mining company. The Company's projects consist of CuMo Project in Idaho and ...
View More »